Fisher & Paykel Healthcare Corporation LimitedFisher & Paykel Healthcare Corporation LimitedFisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪10.92 B‬EUR
‪197.97 M‬EUR
‪1.06 B‬EUR
‪555.26 M‬
Beta (1Y)
1.54
Employees (FY)
‪7.54 K‬
Change (1Y)
+394 +5.52%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Fisher & Paykel Healthcare Corporation Limited


CEO
Lewis George Gradon
Headquarters
Auckland
Founded
1934
IPO date
Nov 13, 2001
Identifiers
2
ISIN NZFAPE0001S2
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.

Check out other big names from the same industry as FPLB.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
VXUS
Vanguard Total International Stock ETF
Weight
0.03%
Market value
‪183.48 M‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.04%
Market value
‪118.61 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.05%
Market value
‪90.61 M‬
USD
EFA
iShares MSCI EAFE ETF
Weight
0.06%
Market value
‪45.01 M‬
USD
BBAX
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
Weight
0.59%
Market value
‪37.48 M‬
USD
SCHF
Schwab International Equity ETF
Weight
0.05%
Market value
‪29.19 M‬
USD
VEU
Vanguard FTSE All World Ex US ETF
Weight
0.03%
Market value
‪27.35 M‬
USD
IWDG
iShares Core MSCI World UCITS ETF Hedged GBP
Weight
0.02%
Market value
‪25.50 M‬
USD
SWDA
iShares Core MSCI World UCITS ETF
Weight
0.02%
Market value
‪25.50 M‬
USD
IWDD
iShares III PLC - iShares Core MSCI World UCITS ETF USD
Weight
0.02%
Market value
‪25.50 M‬
USD
IWLE
iShares Core MSCI World UCITS ETF Hedged (Dist)
Weight
0.02%
Market value
‪25.50 M‬
USD

Explore more ETFs 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Fisher & Paykel Healthcare Corporation Limited stocks are traded under the ticker FPLB.
We've gathered analysts' opinions on Fisher & Paykel Healthcare Corporation Limited future price: according to them, FPLB price has a max estimate of 24.88 EUR and a min estimate of 15.36 EUR. Watch FPLB chart and read a more detailed Fisher & Paykel Healthcare Corporation Limited stock forecast: see what analysts think of Fisher & Paykel Healthcare Corporation Limited and suggest that you do with its stocks.
FPLB reached its all-time high on Nov 29, 2024 with the price of 21.8 EUR, and its all-time low was 10.2 EUR and was reached on Oct 13, 2022. View more price dynamics on FPLB chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Fisher & Paykel Healthcare Corporation Limited financials in yearly and quarterly reports right on TradingView.
Fisher & Paykel Healthcare Corporation Limited is going to release the next earnings report on May 27, 2026. Keep track of upcoming events with our Earnings Calendar.
FPLB earnings for the last half-year are 0.18 EUR per share, whereas the estimation was 0.17 EUR, resulting in a 5.26% surprise. The estimated earnings for the next half-year are 0.20 EUR per share. See more details about Fisher & Paykel Healthcare Corporation Limited earnings.
Fisher & Paykel Healthcare Corporation Limited revenue for the last half-year amounts to ‪537.37 M‬ EUR, despite the estimated figure of ‪530.49 M‬ EUR. In the next half-year revenue is expected to reach ‪596.98 M‬ EUR.
FPLB net income for the last half-year is ‪105.15 M‬ EUR, while the previous report showed ‪117.56 M‬ EUR of net income which accounts for −10.56% change. Track more Fisher & Paykel Healthcare Corporation Limited financial stats to get the full picture.
Yes, FPLB dividends are paid semi-annually. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (TTM)% is 1.38%. Tracking Fisher & Paykel Healthcare Corporation Limited dividends might help you take more informed decisions.
Fisher & Paykel Healthcare Corporation Limited dividend yield was 1.49% in 2024, and payout ratio reached 77.62%. The year before the numbers were 1.90% and 214.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 16, 2026, the company has ‪7.54 K‬ employees. See our rating of the largest employees — is Fisher & Paykel Healthcare Corporation Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fisher & Paykel Healthcare Corporation Limited EBITDA is ‪368.58 M‬ EUR, and current EBITDA margin is 32.22%. See more stats in Fisher & Paykel Healthcare Corporation Limited financial statements.
Like other stocks, FPLB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fisher & Paykel Healthcare Corporation Limited stock right from TradingView charts — choose your broker and connect to your account.